GLP-1 & incretin medicines

Foundayo

orforglipron · Small-molecule (non-peptide) oral GLP-1 receptor agonist · Eli Lilly

✓Last reviewed · Written by Dr. George Grunberger · Medical review: pending — clinician review in progress · How we review

In short

Foundayo (orforglipron) is a small-molecule (non-peptide) oral GLP-1 receptor agonist made by Eli Lilly, used for weight reduction and long-term maintenance in adults with obesity, or overweight with at least one weight-related condition. Schedule: once daily. It is prescription-only in the US and Canada.

FormTablet
How oftenOnce daily
United StatesFDA-approved April 1, 2026. Not approved for type 2 diabetes in the US (Lilly has filed in many countries).
CanadaCheck the Health Canada Drug Product Database for current status.
PrescriptionRequired
⚠ Boxed warning: risk of thyroid C-cell tumors. Do not use if you or a family member has had medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What it is used for

  • Weight reduction and long-term maintenance in adults with obesity, or overweight with at least one weight-related condition

Foundayo dosage

Per the official label. Your prescriber sets your dose — never change it on your own.

Foundayo label dosing schedule
1Days 1–300.8 mg daily
2Days 31–602.5 mg daily
3Days 61–905.5 mg daily (lowest maintenance dose)
4If needed9 mg, 14.5 mg or 17.2 mg daily, each step after at least 30 days
5Maximum17.2 mg daily (9 mg with strong CYP3A4 inhibitors)
Foundayo dose stepsDays 1–30: 0.8 mg; Days 31–60: 2.5 mg; Days 61–90: 5.5 mg; If needed: 9 mg; Maximum: 17.2 mg0.8 mgDays 1–302.5 mgDays 31–605.5 mgDays 61–909 mgIf needed17.2 mgMaximum
Foundayo label titration, step by step. Doses go up only as tolerated and as your prescriber decides.

How to take it

Take once daily at any time, with or without food or water — no fasting rule.

Storage

Room temperature in the original container.

Side effects

Common

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Indigestion / heartburn
  • Fatigue
  • Decreased appetite

Serious — get medical help

  • Pancreatitis (severe stomach pain that may spread to the back)
  • Gallbladder problems, including gallstones
  • Low blood sugar when combined with insulin or a sulfonylurea
  • Kidney problems, often from dehydration after vomiting or diarrhea
  • Serious allergic reactions
  • Diabetic retinopathy complications (people with type 2 diabetes)
  • Pulmonary aspiration during anesthesia or deep sedation — tell your surgical team you take it

Who should not use it

  • Personal or family history of medullary thyroid carcinoma, or MEN 2
  • Prior serious allergic reaction to the drug or its ingredients
  • Pregnancy (stop before a planned pregnancy as advised by your prescriber)
  • Use together with another GLP-1 receptor agonist

Cost

LillyDirect self-pay launched at $149/month (0.8 mg), $199 (2.5 mg) and $299 (higher doses). With commercial coverage, a savings card may bring it to $25/month. Verify before filling.

GLP-1 cost without insurance →

How to buy Foundayo legally

  1. Get a prescription from your doctor or a licensed telehealth provider.
  2. Fill it at a licensed pharmacy, or through the manufacturer's self-pay pharmacy.
  3. Verify any online pharmacy first (US: safe.pharmacy; Canada: your provincial pharmacy college register).

Buying legally in the USA → Buying legally in Canada →

Common questions

Frequently asked questions

How is Foundayo different from the Wegovy pill?

Foundayo is a small molecule with no food or water restrictions. The Wegovy pill is semaglutide and must be taken fasting.

How much weight do people lose on Foundayo?

In the 72-week ATTAIN-1 trial, the highest dose averaged about 12% body-weight loss versus about 1% on placebo.

Also searched as: orforglipron, Foundayo pill, Foundayo tablet, Lilly weight loss pill, Foundayo price, Foundayo side effects, orforglipron price, Fondayo, Foundyo

Sources

Checked against these primary sources on .

Contact
Esc

↑↓ navigate↵ open